Leading With Science

Alimentiv’s model attracts eyes across the medical community and beyond. Here are the latest stories people are telling about us, our mission and our unique Health Trust.

Read More

2022

2 items + icon for opening accordian - icon for closing accordian
The IBUS Group E.V. and Alimentiv Inc. Announce Partnership to Implement Intestinal Ultrasound Central Reading Services in Clinical Trials for Inflammatory Bowel Disease

London, ON, CANADA, Release: January 27, 2022 The International Bowel Ultrasound (IBUS) Group e.V. and Alimentiv Inc. announced today a partnership to offer intestinal ultrasound (IUS) central reading services in clinical trials of adults and children with inflammatory bowel disease (IBD). Owing to its cost-effectiveness, tolerability and repeatability, IUS has played an increasing role as… read more

Implementation of Histopathology in GI Clinical Trials

Join our expert panel where they will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including Histopathology as a treatment target in IBD: Aspiration or Reality? Measuring histopathology in IBD trials Histopathology as a treatment target… read more

2021

7 items + icon for opening accordian - icon for closing accordian
Women in Leadership – Judi Hall

Alimentiv is proud to continuously honour and recognize the achievements of women and foster this culture globally amongst our employees and prospective candidates. This month, we are taking time to highlight Judi Hall, Vice President, Clinical Research for Alimentiv. Judi took some time to discuss her growth and development within the company, motivation, and inspiration… read more

Alimentiv Selects Veeva Vault to Launch eTMF Solution

London, ON, CANADA, Release: August 12, 2021 –Alimentiv, Inc. announced today the launch of their new eTMF solution in partnership with Veeva Vault eTMF, offering sponsors real-time data and secure access to all clinical documentation throughout the clinical trial lifecycle. As part of its strategy to modernize its technology landscape, Alimentiv selected Vault eTMF to improve… read more

Women In Leadership

Alimentiv is proud to continuously honour and recognize the achievements of women and foster this culture globally amongst our employees and prospective candidates. This month, we are taking time to highlight Arti Ramji, Senior Manager, Human Resources & Engagement for Alimentiv. Arti took some time to discuss her growth and development within the company, motivation,… read more

Alimentiv Welcomes Mike Reffeitt As New Chief Financial Officer

Alimentiv is pleased to announce that Mike Reffeitt joined Alimentiv Inc. as the new Chief Financial Officer, effective Monday, May 3, 2021. Mike will be working alongside the executive team to drive the business and strategy of the Alimentiv group of companies forward and support our corporate operations teams including IT, legal, quality, facilities, and… read more

Alimentiv Health Trust Launches AcelaBio (US) Inc. A Commercial State-of-the-art Research Laboratory Delivering Histopathology And Precision Medicine Services For Global Clinical Trials

London, ON, CANADA, Release: April 14, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), and McDougall Scientific Ltd., a niche CRO, announced today the launch of AcelaBio, a commercial state-of-the-art research laboratory delivering histopathology and precision medicine services for… read more

International Women’s Day And Our Alimentiv Leaders

International Women’s Day 2021 is on Monday, March 8th. Alimentiv is proud to celebrate this, honour the achievements of women across the globe, and continues to foster a culture where all employees and prospective candidates receive equal opportunities…. read more

Alimentiv Announces Acquisition of McDougall Scientific Ltd.

London, ON, CANADA, Release: March 2, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), announced today the acquisition of McDougall Scientific Ltd. a niche CRO specializing in statistical analysis, top-tier data management, reporting, and clinical trial design. The acquisition… read more

2020

5 items + icon for opening accordian - icon for closing accordian
PRO Development

A patient reported outcome measure, or PRO, may be defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else.” These measures are widely used to study chronic diseases and are considered by regulatory agencies such… read more

Gutsy Walk – Alimentiv Corporate Team

Our corporate team “IBD Eliminators” are featured as the Corporate Team for Gutsy Walk! Including dedicated employees of Alimentiv Clinical Trials and supportive friends and family, our team has participated since 2017…. read more

Alimentiv Launch Announced

Alimentiv, Inc. formerly Robarts Clinical Trials, announced today a major rebranding to reflect the company’s continued growth as a specialized global gastrointestinal (GI) contract research organization (CRO)…. read more

Alimentiv COVID-19 Announcement

Alimentiv’s Response to the COVID-19 pandemic and how we are still working to provide safe, quality service to our partners, sponsors, vendors and investigators…. read more